Sanbio B.V.

Sanbio B.V. company information, Employees & Contact Information

Updated June 2026

Quick answer

Sanbio B.V. is a Biotechnology company and founded in 1978. It has approximately 16 employees on record. Contact data was last refreshed in June 2026. Find Sanbio B.V.'s verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

As an independent distributor and manufacturer of life science products and services for research and diagnostics, we strive to build long-term relationships with both our clients and suppliers. In accomplishing our mission, it is our experience that knowledge makes the difference. Sanbio is part of Europa Biosite, a European supplier of life science products and services. We are a group of six leading distribution companies: Biomol in Germany, Cambridge Bioscience in the UK and Ireland, LubioScience in Switzerland, Nordic BioSite in the Nordics and Baltics, Sanbio in Benelux and Szabo-Scandic in Austria. The group has a portfolio of over 5 million products, representation in 15 European countries and a highly skilled team of over 150 employees.

Company Details

Employees
16
Founded
1978
Address
Frontstraat 2c, Postbus 540,netherlands
Phone
31 413 251115
Email
su****@****nbio.nl
Industry
Biotechnology
Website
sanbio.nl
HQ
UDEN
Looking for a particular Sanbio B.V. employee's phone or email?

Sanbio B.v. Questions

News

SanBio Awaits Regulatory Decision on AKUUGO Suspension - TipRanks

SanBio Awaits Regulatory Decision on AKUUGO Suspension TipRanks

SanBio Stock Surge: A New Hope in Brain Injury Treatment - Meyka

SanBio Stock Surge: A New Hope in Brain Injury Treatment Meyka

SanBio Co. Reports Losses Amid R&D Investments - TipRanks

SanBio Co. Reports Losses Amid R&D Investments TipRanks

SanBio Obtains Marketing Approval for "AKUUGO® Suspension for Intracranial Implantation" (INN: Vandefitemcel) as a Therapeutic Agent for Improving Chronic Motor Paralysis From Traumatic Brain Injury (TBI) - Yahoo Finance

SanBio Obtains Marketing Approval for "AKUUGO® Suspension for Intracranial Implantation" (INN: Vandefitemcel) as a Therapeutic Agent for Improving Chronic Motor Paralysis From Traumatic Brain Injury (TBI) Yahoo Finance

SanBio publishes interim data from traumatic brain injury trial - Clinical Trials Arena

SanBio publishes interim data from traumatic brain injury trial Clinical Trials Arena

Japan’s Sanbio submits BLA for brain injury regenerative therapy under Sakigake designation system - BioWorld MedTech

Japan’s Sanbio submits BLA for brain injury regenerative therapy under Sakigake designation system BioWorld MedTech

SanBio Awarded RMAT for SB623, a Modified Stem Cell Treatment for TBI - BioInformant

SanBio Awarded RMAT for SB623, a Modified Stem Cell Treatment for TBI BioInformant

Top Sanbio B.V. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant